Business Description
Hisamitsu Pharmaceutical Co Inc
ISIN : US43358N1072
Share Class Description:
HTSUY: ADRTotal Employee Number:
3,697Description
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 49.95 | |||||
Equity-to-Asset | 0.8 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.08 | |||||
Interest Coverage | 853.24 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 5.74 | |||||
Beneish M-Score | -2.21 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.2 | |||||
3-Year EBITDA Growth Rate | 17.5 | |||||
3-Year EPS without NRI Growth Rate | 22.7 | |||||
3-Year FCF Growth Rate | 29.6 | |||||
3-Year Book Growth Rate | 7.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 10.23 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.04 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-1 Month Momentum % | -55.79 | |||||
6-1 Month Momentum % | -55.79 | |||||
12-1 Month Momentum % | -56.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.08 | |||||
Quick Ratio | 3.57 | |||||
Cash Ratio | 2.35 | |||||
Days Inventory | 135.33 | |||||
Days Sales Outstanding | 111.5 | |||||
Days Payable | 57.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.33 | |||||
Dividend Payout Ratio | 0.22 | |||||
3-Year Dividend Growth Rate | -18.8 | |||||
Forward Dividend Yield % | 6.01 | |||||
5-Year Yield-on-Cost % | 2.17 | |||||
3-Year Average Share Buyback Ratio | 3.3 | |||||
Shareholder Yield % | -0.23 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 58.96 | |||||
Operating Margin % | 10.99 | |||||
Net Margin % | 11.75 | |||||
EBITDA Margin % | 18.85 | |||||
FCF Margin % | 5.63 | |||||
OCF Margin % | 10.43 | |||||
ROE % | 6.97 | |||||
ROA % | 5.56 | |||||
ROIC % | 7.03 | |||||
3-Year ROIIC % | 9.31 | |||||
ROC (Joel Greenblatt) % | 25.4 | |||||
ROCE % | 8.01 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 14.8 | |||||
Forward PE Ratio | 6.39 | |||||
PE Ratio without NRI | 14.61 | |||||
Shiller PE Ratio | 18.23 | |||||
PEG Ratio | 0.72 | |||||
PS Ratio | 1.76 | |||||
PB Ratio | 0.96 | |||||
Price-to-Tangible-Book | 0.98 | |||||
Price-to-Free-Cash-Flow | 30.08 | |||||
Price-to-Operating-Cash-Flow | 16.23 | |||||
EV-to-EBIT | 13.17 | |||||
EV-to-EBITDA | 10.15 | |||||
EV-to-Revenue | 1.91 | |||||
EV-to-FCF | 33.08 | |||||
Price-to-GF-Value | 0.55 | |||||
Price-to-Projected-FCF | 0.82 | |||||
Price-to-Median-PS-Value | 0.59 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.63 | |||||
Price-to-Graham-Number | 0.8 | |||||
| Price-to-Net-Current-Asset-Value | 2.15 | |||||
| Price-to-Net-Cash | 6.53 | |||||
Earnings Yield (Greenblatt) % | 7.59 | |||||
FCF Yield % | 2.22 | |||||
Forward Rate of Return (Yacktman) % | 22.25 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HTSUY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hisamitsu Pharmaceutical Co Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,080.212 | ||
| EPS (TTM) ($) | 0.443 | ||
| Beta | 0.2073 | ||
| 3-Year Sharpe Ratio | -0.41 | ||
| 3-Year Sortino Ratio | -0.5 | ||
| Volatility % | 55.86 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 0.044753 | ||
| 20-Day SMA ($) | 2.94 | ||
| 12-1 Month Momentum % | -56.73 | ||
| 52-Week Range ($) | 2.94 - 6.795 | ||
| Shares Outstanding (Mil) | 281.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hisamitsu Pharmaceutical Co Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hisamitsu Pharmaceutical Co Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| USD 0.097860 Cash Dividend | 2025-08-29 | 6.80 (+0.00%) | ||
| USD 0.078770 Cash Dividend | 2025-02-28 | 6.75 (+0.00%) | ||
| USD 0.073085 Cash Dividend | 2024-08-30 | 7.30 (+0.00%) |
Show
Entries
Hisamitsu Pharmaceutical Co Inc Frequently Asked Questions
What is Hisamitsu Pharmaceutical Co Inc(HTSUY)'s stock price today?
The current price of HTSUY is $2.94. The 52 week high of HTSUY is $6.80 and 52 week low is $2.94.
When is next earnings date of Hisamitsu Pharmaceutical Co Inc(HTSUY)?
The next earnings date of Hisamitsu Pharmaceutical Co Inc(HTSUY) is .
Does Hisamitsu Pharmaceutical Co Inc(HTSUY) pay dividends? If so, how much?
The Dividend Yield %  of Hisamitsu Pharmaceutical Co Inc(HTSUY) is 3.33% (As of Today), Highest Dividend Payout Ratio of Hisamitsu Pharmaceutical Co Inc(HTSUY) was 0.75. The lowest was 0.17. And the median was 0.37. The  Forward Dividend Yield % of Hisamitsu Pharmaceutical Co Inc(HTSUY) is 6.01%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on OTCPK:HTSUY
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Hisamitsu Pharmaceutical Co Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers